Biotech Environment in 2016: Reverse Engineering the Ecosystem #BES2016
BIO-Europe Spring 2016 is starting off right away with the plenary opening session. The conference…
BIO-Europe Spring 2016 is starting off right away with the plenary opening session. The conference…
AstraZeneca, GlaxoSmithKline, Johnson & Johnson and the 3 world-leading universities (Imperial College London, University College…
Marseille's Innate Pharma is building an Immuno-Oncology Monopoly, deal by deal. Selling to the French…
Illumina, the €22Bn Market cap NGS specialist, and Bill Gates pooled a $100M to fund…
Acerta Pharma is an elusive Netherlands based Biotech with pipelines in Blood cancer and solid…
AstraZeneca's Senior management team gets reinforced by Sean Bohen, a top executive from Roche's subsidiary…
Heptares Therapeutics, the GPCR-targeted drug company, and British pharma giant AstraZeneca entered a new collaboration…
Isis Pharmaceuticals and AstraZeneca extend their collaboration to discover and develop antisense therapies. After cancer,…
The Pharma giant AstraZeneca is still struggling even if in better shape. It just sold…
The big pharma companies Eli Lilly and AstraZeneca will combine two of their cancer drugs…
Orca Pharmaceuticals, and AstraZeneca embarked on a three year collaboration to develop inhibitors of retinoic…
Medimmune, the global biologics research and development arm of Anglo-Swedish drug major AstraZeneca, has entered…